ArticlePharmaceuticals (Basel, Switzerland)2020

The Combination of Afatinib and Bevacizumab in Untreated EGFR-Mutated Advanced Lung Adenocarcinoma: A Multicenter Observational Study.

Ping-Chih Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.